Orphapacket:
  AverageAgeOfOnsets:
    AverageAgeOfOnset:
    - value: All ages
  Childs: []
  DisorderType:
    PURL: http://www.orpha.net/ORDO/Orphanet_377788
    value: Disease
  ExternalReferences:
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHAcode is broader than the targeted code used
        to represent it)
      Reference: '607085'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHAcode is broader than the targeted code used
        to represent it)
      Reference: '159400'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: 'E (Exact mapping: the two concepts are equivalent)'
      Reference: '254200'
      Source: OMIM
  Label: Myasthenia gravis
  ORPHAcode: '589'
  ORPHApacketId: '589'
  PURL: http://www.orpha.net/ORDO/Orphanet_589
  Parents:
  - Parent:
    - Label: Rare neuromuscular disorder with ocular motility/alignment anomaly
      ORPHAcode: '519347'
  - Parent:
    - Label: Immune-mediated acquired neuromuscular junction disease
      ORPHAcode: '464764'
  - Parent:
    - Label: Disease associated with a genetic susceptibility or tested for a biomarker
      ORPHAcode: '231957'
  Phenotypes:
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0001324
      HPOTerm: Muscle weakness
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000508
      HPOTerm: Ptosis
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000597
      HPOTerm: Ophthalmoparesis
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000651
      HPOTerm: Diplopia
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000777
      HPOTerm: Abnormality of the thymus
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001260
      HPOTerm: Dysarthria
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001283
      HPOTerm: Bulbar palsy
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001618
      HPOTerm: Dysphonia
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002015
      HPOTerm: Dysphagia
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002094
      HPOTerm: Dyspnea
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0003202
      HPOTerm: Skeletal muscle atrophy
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0003551
      HPOTerm: Difficulty climbing stairs
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0003690
      HPOTerm: Limb muscle weakness
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0010516
      HPOTerm: Thymus hyperplasia
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0012378
      HPOTerm: Fatigue
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0030006
      HPOTerm: Single fiber EMG abnormality
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0030197
      HPOTerm: Fatigable weakness of skeletal muscles
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0030208
      HPOTerm: Acetylcholine receptor antibody positivity
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0030210
      HPOTerm: Muscle specific kinase antibody positivity
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0030319
      HPOTerm: Weakness of facial musculature
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0100614
      HPOTerm: Myositis
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:5000038
      HPOTerm: Anti-titin antibody positivity
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:5000047
      HPOTerm: Anti-ryanodine receptor antibody
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:5000048
      HPOTerm: Anti-Kv1.4 antibody
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0000365
      HPOTerm: Hearing impairment
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0000836
      HPOTerm: Hyperthyroidism
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0000872
      HPOTerm: Hashimoto thyroiditis
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0001370
      HPOTerm: Rheumatoid arthritis
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002725
      HPOTerm: Systemic lupus erythematosus
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002878
      HPOTerm: Respiratory failure
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0003076
      HPOTerm: Glycosuria
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0003401
      HPOTerm: Paresthesia
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0008207
      HPOTerm: Primary adrenal insufficiency
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0010780
      HPOTerm: Hyperacusis
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0012473
      HPOTerm: Tongue atrophy
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0030880
      HPOTerm: Raynaud phenomenon
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0100522
      HPOTerm: Thymoma
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:5000046
      HPOTerm: Anti-Lrp4 antibody positivity
  - Phenotype:
      HPOFrequency: Very rare (<4-1%)
      HPOId: HP:0000709
      HPOTerm: Psychosis
  - Phenotype:
      HPOFrequency: Very rare (<4-1%)
      HPOId: HP:0001063
      HPOTerm: Acrocyanosis
  - Phenotype:
      HPOFrequency: Very rare (<4-1%)
      HPOId: HP:0001250
      HPOTerm: Seizure
  - Phenotype:
      HPOFrequency: Very rare (<4-1%)
      HPOId: HP:0001878
      HPOTerm: Hemolytic anemia
  - Phenotype:
      HPOFrequency: Very rare (<4-1%)
      HPOId: HP:0012115
      HPOTerm: Hepatitis
  - Phenotype:
      HPOFrequency: Very rare (<4-1%)
      HPOId: HP:0012410
      HPOTerm: Pure red cell aplasia
  Prevalences:
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 20130418[PMID]_[EXPERT]_ ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 17986328[PMID]_[EXPERT]_European Medicines Agency 2018[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Worldwide
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 20565885[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: United States
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 8909435[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Canada
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 14664466[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Spain
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 12654975[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: United Kingdom
      PrevalenceQualification: Value and class
      PrevalenceType: Lifetime Prevalence
      Source: 10733998[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: United Kingdom
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 9771771[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: United Kingdom
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 9771771[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Serbia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 23363926[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: United States
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 8909435[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Serbia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 23363926[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Italy
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 21757957[PMID]_20623298[PMID]_ ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Austria
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 23129486[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Australia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 22469211[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Italy
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21757957[PMID]_22377708[PMID]_ ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Taiwan, Province of China
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 20523074[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Australia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 22469211[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Greece
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 11511710[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Taiwan, Province of China
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 20523074[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Croatia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 9705586[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Estonia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 14638881[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Greece
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 11511710[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Croatia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 9705586[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Egypt
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 20948236[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Worldwide
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 20565885[PMID]
      ValMoy: no data
  Synonyms:
  - Synonym: Acquired myasthenia
  - Synonym: Autoimmune myasthenia gravis
  TextSection:
    Contents: Myasthenia gravis (MG) is a rare clinically heterogeneous autoimmune
      disorder of the neuromuscular junction characterized by fatigable weakness of
      voluntary muscles.
    TextSectionType: Definition
  TypeOfInheritances:
  - TypeOfInheritance:
      value: Multigenic/multifactorial
  - TypeOfInheritance:
      value: Not applicable
  copyright: Orphanet (c) 2024
  creationDate: '2024-07-01 09:48:26'
  version: 1.3.29 / 4.1.7 [2023-08-02] (orientdb version)
